A1: no patient specific details have been provided.Therefore, the patient identifier reflects the study number with codes for the hospital and patient.H3: other: engineering evaluation could not be performed as the device remains implanted.H6: evaluation codes investigation findings c19 refers to the product history review: a review of the manufacturing records indicated the lots met pre-release specifications.It was stated that catheterisation of the tips stent was not possible.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
The following was reported to gore on 2/28/24 from the video study database: on (b)(6) 2024, this 40-year-old patient underwent implantation of two gore® viatorr® tips endoprosthesis with controlled expansion devices in the portal vein for treatment of ascites.The second gore® viatorr® tips endoprosthesis with controlled expansion device was implanted due to stenosis in the liver vein.A gore® tips set was used during the procedure.There were multiple punctures due to the short tract between the liver vein and portal vein.The patient had difficult anatomy.The study devices were successfully delivered during the procedure and the stents were dilated twice post deployment.On february 15, 2024 the patient was noted to have a reintervention related to study device occlusion or shunt dysfunction.It was noted that catheterization of the tips stent was not possible and patency was not restored.On february 22, 2024 the patient was noted to have a reintervention related to study device occlusion or shunt dysfunction.It was noted that catheterization of the tips stent was again not possible and patency was not restored.
|